CRISPR and the wider editing toolkit – delivery, specificity, and the systems engineered to make edits safer and more precise.
46 articles
Researchers from the University of Toronto and the University of Otago have discovered five new proteins that block the bacterial CRISPR/Cas immune system. The anti-CRISPR proteins are...
Researchers at the IBS Center for Genome Editing in South Korea have successfully created mutant mice using CRISPR/Cpf1. The alternative to the well-known CRISPR/Cas9 system can...
Bio-Rad presented at Analytica the ultra-sensitive properties of digital droplet PCR (ddPCR) to quantify homology directed repair (HDR) and non-homologous end joining (NHEJ) events in...
CRISPR/Cas9 co-discoverer Emmanuelle Charpentier and collaborators from Germany and Sweden have found that Cas nuclease Cpf1 cleaves DNA and RNA. Cpf1 cuts a precursor of crRNA to produce the...
Veritas Genetics has announced its $1,000 whole genome sequencing service whose results will be browsable on smartphones. The MyGenome service announced last year and set to...
The Human Fertilisation and Embryology Authority (HFEA) has approved the use of the gene editing tool CRISPR on human embryos for research purposes. After a...
Researchers from UC Berkeley have improved CRISPR/Cas9 gene editing performance by 60%. The team designed a specific DNA template that has the desired sequence and...
Clontech has launched the Guide-it CRISPR/Cas9 Gesicle Production System, a new technology that improves CRISPR/Cas9 delivery and reduces its footprint. Cas9 endonucleases and target-specific sgRNAs are encapsulated...
